Highlights and Quick Summary
- Research and Development Expense of Revenue for the quarter ending December 31, 2022 was 26864.29% (a Infinity% increase compared to previous quarter)
- Year-over-year quarterly Research and Development Expense of Revenue increased by 493.96%
- Annual Research and Development Expense of Revenue for 2022 was 15441.1% (a Infinity% increase from previous year)
- Annual Research and Development Expense of Revenue for 2022 was 0.0% (a -100.0% decrease from previous year)
- Annual Research and Development Expense of Revenue for 2021 was 11898.31% (a 0.0% decrease from previous year)
- Twelve month Research and Development Expense of Revenue ending December 31, 2022 was 13525.29% (a Infinity% increase compared to previous quarter)
- Twelve month trailing Research and Development Expense of Revenue decreased by -1.32% year-over-year
Trailing Research and Development Expense of Revenue for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| 13525.29% | 0.0% | 15029.33% | 13706.58% |
Visit stockrow.com/BNTC
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Research and Development Expense of Revenue of Benitec Biopharma Limited
Most recent Research and Development Expense of Revenueof BNTC including historical data for past 10 years.Interactive Chart of Research and Development Expense of Revenue of Benitec Biopharma Limited
Benitec Biopharma Limited Research and Development Expense of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 26864.29% | 0.0% | 0.0% | 4522.92% | 15441.1% |
| 2021 | 12584.0% | 0.0% | 116000.0% | 275800.0% | 11898.31% |
| 2020 | 116800.0% | 1407.27% | -3261.11% | 2875.0% | 2942.16% |
| 2019 | – | – | 777.92% | 1281.82% | 37.44% |
| 2018 | – | – | – | – | 146.38% |
| 2017 | – | – | – | 160.12% | 62.43% |
| 2016 | – | – | – | 43.44% | 327.76% |
| 2015 | – | – | – | – | 156.8% |
| 2014 | – | – | – | – | 273.56% |
| 2013 | – | – | – | – | 87.42% |
Business Profile of Benitec Biopharma Limited
Sector: Healthcare
Industry: Biotechnology